glp-1 agonist clinical trials Another milestone in the evolution of GLP-1-based diabetes therapies GLP-1 Receptor Agonists for Weight

In contrast, recommendations for treatment selection in the second-line setting have been outlined in international guidelines, such as the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) guidelines, which inform choice of treatment according to an individuals CV and chronic kidney disease (CKD) risk [15]

I know it can be difficult to make that a priority regularly

However, this is less of an issue for well-known class-specific adverse effects

Beaven SW, Matveyenko A, Wroblewski K et al (2013) Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance

Preclinical studies with various types of GLP-1RAs have demonstrated reductions in alcohol intake 7,8,9,10,11,12,13,14,15

Fasting, Circadian rhythms, and time-restricted feeding in healthy lifespan